Spacer length shapes drug release and therapeutic efficacy of traceless disulfide-linked ADCs targeting the tumor neovasculature
出版年份 2012 全文链接
标题
Spacer length shapes drug release and therapeutic efficacy of traceless disulfide-linked ADCs targeting the tumor neovasculature
作者
关键词
-
出版物
Chemical Science
Volume 4, Issue 1, Pages 297-302
出版商
Royal Society of Chemistry (RSC)
发表日期
2012-10-09
DOI
10.1039/c2sc21107f
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules
- (2012) Anna Perols et al. BIOCONJUGATE CHEMISTRY
- Fucose-specific conjugation of hydrazide derivatives to a vascular-targeting monoclonal antibody in IgG format
- (2012) Kathrin Zuberbühler et al. CHEMICAL COMMUNICATIONS
- The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
- (2012) N. Pasche et al. CLINICAL CANCER RESEARCH
- Antibody–drug conjugates: Basic concepts, examples and future perspectives
- (2012) Giulio Casi et al. JOURNAL OF CONTROLLED RELEASE
- Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery
- (2012) Giulio Casi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates
- (2012) Mauro Acchione et al. mAbs
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- A “Tag-and-Modify” Approach to Site-Selective Protein Modification
- (2011) Justin M. Chalker et al. ACCOUNTS OF CHEMICAL RESEARCH
- Selenenylsulfide-Linked Homogeneous Glycopeptides and Glycoproteins: Synthesis of Human “Hepatic Se Metabolite A”
- (2011) Omar Boutureira et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
- (2011) Gonçalo J. L. Bernardes et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Disulfide-Linked Antibody−Maytansinoid Conjugates: Optimization of In Vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage
- (2011) Brenda A. Kellogg et al. BIOCONJUGATE CHEMISTRY
- Tunable Degradation of Maleimide–Thiol Adducts in Reducing Environments
- (2011) Aaron D. Baldwin et al. BIOCONJUGATE CHEMISTRY
- A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels
- (2011) A Palumbo et al. BRITISH JOURNAL OF CANCER
- Interplay of Chemical Microenvironment and Redox Environment on Thiol-Disulfide Exchange Kinetics
- (2011) Chuanliu Wu et al. CHEMISTRY-A EUROPEAN JOURNAL
- The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
- (2011) Kathrin Schwager et al. HUMAN REPRODUCTION
- Combination Radioimmunotherapy and Chemoimmunotherapy Involving Different or the Same Targets Improves Therapy of Human Pancreatic Carcinoma Xenograft Models
- (2011) R. M. Sharkey et al. MOLECULAR CANCER THERAPEUTICS
- Methods for converting cysteine to dehydroalanine on peptides and proteins
- (2011) Justin M. Chalker et al. Chemical Science
- Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies
- (2010) Michael Fiechter et al. ATHEROSCLEROSIS
- Physicochemical Stability of the Antibody−Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation Processes
- (2010) Aditya A. Wakankar et al. BIOCONJUGATE CHEMISTRY
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Chemical mutagenesis: selective post-expression interconversion of protein amino acid residues
- (2010) Justin M Chalker et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
- (2010) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibody drug-conjugates targeting the tumor vasculature
- (2010) Hans-Peter Gerber et al. mAbs
- Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation
- (2010) Champak Chatterjee et al. Nature Chemical Biology
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients
- (2009) S. Sauer et al. BLOOD
- Potent antibody drug conjugates for cancer therapy
- (2009) Peter D Senter CURRENT OPINION IN CHEMICAL BIOLOGY
- From Disulfide- to Thioether-Linked Glycoproteins
- (2008) Gonçalo J. L. Bernardes et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
- (2008) C. Schliemann et al. BLOOD
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculaturein vivo
- (2008) Alessandra Villa et al. INTERNATIONAL JOURNAL OF CANCER
- Facile Conversion of Cysteine and Alkyl Cysteines to Dehydroalanine on Protein Surfaces: Versatile and Switchable Access to Functionalized Proteins
- (2008) Gonçalo J. L. Bernardes et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemical site-selective prenylation of proteins
- (2008) David P. Gamblin et al. Molecular BioSystems
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started